Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00663871 · ClinicalTrials.gov registry record · NA
Evaluating the Effects of Omega-3 Fatty Acids on Heart Disease and Behavior
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 272
- Enrollment target
NCT00663871 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 272 participants.
The verdict
NCT00663871, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 272 participants
- Enrollment target
Study Summary
Omega-3 fatty acids are a certain kind of fish fat that has recently been shown to have health benefits. This study will examine the effectiveness of fish oil supplementation for reducing the early signs of heart disease risk and for improving mood, impulsivity, and anger levels.
Interventions
- DIETARY_SUPPLEMENT Fish Oil
- DIETARY_SUPPLEMENT Soybean Oil (Placebo)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 272 participants |
| Start Date | 2008-06 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00663871
The ClinicalTrials.gov registry entry for NCT00663871 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 272 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fish Oil is the first listed.
NCT00663871 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00663871 about?
NCT00663871 is a clinical study titled "Evaluating the Effects of Omega-3 Fatty Acids on Heart Disease and Behavior". Omega-3 fatty acids are a certain kind of fish fat that has recently been shown to have health benefits. This study will examine the effectiveness of fish oil supplementation for reducing the early signs of heart disease risk and for improving mood, impulsivity, and anger levels.
What is the current status of trial NCT00663871?
This trial is currently completed. It is a NA study. The enrollment target is 272 participants. The study started on 2008-06. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00663871?
The interventions under investigation include: Fish Oil (DIETARY_SUPPLEMENT), Soybean Oil (Placebo) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00663871?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.